P. Schoenfeld Asset Management (PSAM)’s Alder Biopharmaceuticals ALDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,372,000
Closed -$44.7M 72
2019
Q3
$44.7M Buy
+2,372,000
New +$27.1M 3.6% 9

P. Schoenfeld Asset Management (PSAM)'s ALDR Position: Q4 2019 in Review

P. Schoenfeld Asset Management (PSAM) sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 2,372,000 shares — an estimated $44.7M sold.

P. Schoenfeld Asset Management (PSAM) first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $44.7M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • P. Schoenfeld Asset Management (PSAM) reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • P. Schoenfeld Asset Management (PSAM) sold 2,372,000 Alder Biopharmaceuticals shares in Q4 2019, an estimated $44.7M.
  • P. Schoenfeld Asset Management (PSAM) first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
  • P. Schoenfeld Asset Management (PSAM)'s Alder Biopharmaceuticals position peaked at $44.7M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q4 2019, filed 14 Feb 2020.